首站-论文投稿智能助手
典型文献
Analysis of clinical characteristics of 66 pediatric patients with B.1.617.2(Delta)variant of COVID-19
文献摘要:
Background The aim of this study was to analyze the clinical characteristics of 66 pediatric patients with B.1.617.2(Delta)variant of coronavirus disease 2019(COVID-19).Methods Sixty-six pediatric patients with B.1.617.2(Delta)variant of COVID-19 admitted to the hospital from July to August 2021 were classified into mild(n=41)and moderate groups(n=25).Clinical characteristics,laboratory data and dynamic trends in different time periods were analyzed retrospectively.Results There were no statistically significant differences in age,gender ratios and clinical symptoms between the mild group and the moderate group.All the patients in the moderate group had clusters of onsets,and the incubation period was shorter than that of the mild group.Within 24 hours of admission,the levels of erythrocyte sedimentation rate,cardiac troponin I,D-dimer in the moderate group were higher than that in the mild group(P<0.05).The titers of immunoglobulin(Ig)G and IgM antibodies gradually increased after disease onset.Thirty-five(53.03%)children were tested positive for antibodies in 4-12 days.IgG increased gradually,while IgM decreased obviously in about 15 days after disease onset.The cycle threshold values of open reading frame lab and nucleocapsid protein gene in the severe acute respiratory syndrome coronavirus 2 genomes increased gradually on the 3rd,6th,9th,and 12th days after disease onset,compared with those in day 0.Conclusions The symptoms of children with B.1.617.2(Delta)variant of COVID-19 were mild.The description and analysis of the clinical characteristics and laboratory data can help medical staff to evaluate the condition of children with COVID-19 and to accumulate more clinical experience.
文献关键词:
作者姓名:
Jing Hao;Xiao-Chen Hu;Ming-Xing Fan;Jun Chen;Qi-Rui Cheng;Zhuo Li;Zhi-Liang Hu;Xu-Hua Ge
作者机构:
Pediatric Intensive Care Unit,Children's Hospital of Nanjing Medical University,No 72 Guangzhou Road,Nanjing,China;Nanjing Infectious Disease Center,The Second Hospital of Nanjing,Nanjing University of Chinese Medicine,Nanjing,China
引用格式:
[1]Jing Hao;Xiao-Chen Hu;Ming-Xing Fan;Jun Chen;Qi-Rui Cheng;Zhuo Li;Zhi-Liang Hu;Xu-Hua Ge-.Analysis of clinical characteristics of 66 pediatric patients with B.1.617.2(Delta)variant of COVID-19)[J].世界儿科杂志(英文版),2022(05):343-349
A类:
B类:
Analysis,clinical,characteristics,pediatric,patients,Delta,variant,Background,aim,this,study,was,coronavirus,disease,Methods,Sixty,six,admitted,hospital,from,July,August,were,classified,into,mild,moderate,groups,Clinical,laboratory,data,dynamic,trends,different,periods,analyzed,retrospectively,Results,There,statistically,significant,differences,age,gender,ratios,symptoms,between,All,had,clusters,onsets,incubation,shorter,than,that,Within,hours,admission,levels,erythrocyte,sedimentation,cardiac,troponin,dimer,higher,titers,immunoglobulin,IgM,antibodies,gradually,increased,after,Thirty,five,children,tested,positive,days,IgG,while,decreased,obviously,about,cycle,threshold,values,open,reading,frame,nucleocapsid,protein,gene,severe,acute,respiratory,syndrome,genomes,3rd,6th,9th,12th,compared,those,Conclusions,description,analysis,help,medical,staff,evaluate,condition,accumulate,more,experience
AB值:
0.543447
相似文献
Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey
Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling-School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China;Department of Integrative Oncology,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Department of Oncology,The First Affiliated Hospital,Bengbu Medical College,Bengbu 233010,Anhui Province,China;Department of Nursing,Fuyang Cancer Hospital,Fuyang 236000,Anhui Province,China;Department of Cardiac Rehabilitation,Shanghai First Rehabilitation Hospital,Shanghai 200090,China;Department of Radiation Oncology,Anhui Chest Hospital,Hefei 230022,Anhui Province,China;Department of Anesthesiology,Chaohu Hospital,Anhui Medical University,Hefei 238000,Anhui Province,China
Homeopathy for COVID-19 in primary care:A randomized,double-blind,placebo-controlled trial(COVID-Simile study)
Ubiratan Cardinalli Adler;Maristela Schiabel Adler;Ana Elisa Madureira Padula;Livia Mitchiguian Hotta;Amarilys de Toledo Cesar;José Nelson Martins Diniz;Helen de Freitas Santos;Edson Zangiacomi Martinez-Department of Medicine,Federal University of S?o Carlos,S?o Carlos 13565-905,Brazil;Homeopathy Solidarity Outpatient Extension Program,Mackenzie Presbyterian University,S?o Paulo 01302-907,Brazil;Municipal Center for Integrative and Complementary Practices in Health,Guarulhos 07023-051,Brazil;HN-Cristiano Institute,S?o Paulo 02013-001,Brazil;School Health Unit,Federal University of S?o Carlos,Sao Carlos 13565-905,Brazil;Federal Institute of Education,Science and Technology of S?o Paulo,Birigui 16201-407,Brazil;Department of Social Medicine,Ribeir?o Preto Medical School,University of Sao Paulo,Ribeirao Preto 14049-900,Brazil
Value of contrast-enhanced ultrasound combined with percutaneous ultrasound-guided fine-needle aspiration in the diagnosis of solid pancreatic lesions
Gui Yang;Dai Menghua;Meng Zhilan;Chang Xiaoyan;Tan Li;Zhang Jing;Chen Xueqi;Zhou Tongtong;Zhang Qing;Xiao Mengsu;Lyu Ke;Jiang Yuxin-Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China;Department of Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China;Department of Pathology, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII
Gui Yinli;Bai Wei;Xu Jian;Duan Xinwang;Zhan Feng;Zhao Chen;Jiang Zhenyu;Li Zhijun;Wu Lijun;Liu Shengyun;Yang Min;Wei Wei;Wang Ziqian;Zhao Jiuliang;Wang Qian;Leng Xiaomei;Tian Xinping;Li Mengtao;Zhao Yan;Zeng Xiaofeng;CSTAR co-authors-Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China;Department of Rheumatology, The People’s Hospital of Zhengzhou, Zhengzhou, Henan 450003, China;Department of Rheumatology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China;Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China;Department of Rheumatology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570311, China;Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China;Department of Rheumatology, The Bethune First Hospital of Jilin University, Changchun, Jilin 130021, China;Department of Rheumatology, The Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, China;Department of Rheumatology, The People’s Hospital of Xinjiang Autonomous Region, Urumqi, Xinjiang 830001, China;Department of Rheumatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China;Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China;Department of Rheumatology, Tianjin Medical University General Hospital, Tianjin 300052, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。